期刊论文详细信息
Frontiers in Medicine | |
COVID-19 With Preexisting Hypercoagulability Digestive Disease | |
article | |
Mingshan Jiang1  Jingxi Mu1  Silan Shen1  Hu Zhang1  | |
[1] Department of Gastroenterology, West China Hospital, Sichuan University;Center for Inflammatory Bowel Disease, West China Hospital, Sichuan University;Laboratory of Inflammatory Bowel Disease, Frontiers Science Center for Disease-Related Molecular Network, West China Hospital, Sichuan University | |
关键词: coronavirus disease 2019; hypercoagulability; thromboembolism; SARS-CoV-2; inflammatory bowel disease; | |
DOI : 10.3389/fmed.2020.587350 | |
学科分类:社会科学、人文和艺术(综合) | |
来源: Frontiers | |
【 摘 要 】
The outbreak of coronavirus disease of 2019 (COVID-19) has become a global public health and economic crisis. The advent of hypercoagulability and thrombotic complications can substantially influence the prognosis of COVID-19 patients. In this review, we elaborate on the clinical findings, potential underlying pathogenesis, and therapeutic strategy of hypercoagulability and thromboembolism in COVID-19, particularly focusing on the COVID-19 patients with preexisting digestive hypercoagulability disease.
【 授权许可】
CC BY
【 预 览 】
Files | Size | Format | View |
---|---|---|---|
RO202108180002586ZK.pdf | 183KB | download |